Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 1
2006 1
2007 3
2008 4
2009 2
2010 8
2011 8
2012 8
2013 11
2014 15
2015 10
2016 6
2017 9
2018 18
2019 12
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 31519550

100 results
Results by year
Filters applied: . Clear all
Page 1
Short-Term Effects of Very-Low-Phosphate and Low-Phosphate Diets on Fibroblast Growth Factor 23 in Hemodialysis Patients: A Randomized Crossover Trial.
Tsai WC, Wu HY, Peng YS, Hsu SP, Chiu YL, Yang JY, Chen HY, Pai MF, Lin WY, Hung KY, Chu FY, Tsai SM, Chien KL. Tsai WC, et al. Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1475-1483. doi: 10.2215/CJN.04250419. Epub 2019 Sep 13. Clin J Am Soc Nephrol. 2019. PMID: 31519550 Free PMC article.
Effects of lower versus higher phosphate diets on fibroblast growth factor-23 levels in patients with chronic kidney disease: a systematic review and meta-analysis.
Tsai WC, Wu HY, Peng YS, Hsu SP, Chiu YL, Chen HY, Yang JY, Ko MJ, Pai MF, Tu YK, Hung KY, Chien KL. Tsai WC, et al. Nephrol Dial Transplant. 2018 Nov 1;33(11):1977-1983. doi: 10.1093/ndt/gfy005. Nephrol Dial Transplant. 2018. PMID: 29420827
Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
Iguchi A, Kazama JJ, Yamamoto S, Yoshita K, Watanabe Y, Iino N, Narita I. Iguchi A, et al. Nephron. 2015;131(3):161-6. doi: 10.1159/000440968. Epub 2015 Nov 6. Nephron. 2015. PMID: 26551233 Free article.
Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.
Vervloet MG, van Ittersum FJ, Büttler RM, Heijboer AC, Blankenstein MA, ter Wee PM. Vervloet MG, et al. Clin J Am Soc Nephrol. 2011 Feb;6(2):383-9. doi: 10.2215/CJN.04730510. Epub 2010 Oct 28. Clin J Am Soc Nephrol. 2011. PMID: 21030580 Free PMC article.
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.
Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G; FRENCH Study collaborators. Liabeuf S, et al. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1930-1940. doi: 10.2215/CJN.03030317. Epub 2017 Oct 26. Clin J Am Soc Nephrol. 2017. PMID: 29074818 Free PMC article. Clinical Trial.
Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients.
Sugimoto H, Ogawa T, Iwabuchi Y, Otsuka K, Nitta K. Sugimoto H, et al. Int Urol Nephrol. 2014 Jan;46(1):99-106. doi: 10.1007/s11255-013-0386-2. Epub 2013 Jan 25. Int Urol Nephrol. 2014. PMID: 23355029
Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Hasegawa S, Tanaka S, Eriguchi M, Nakano T, Masutani K, Ooboshi H, Kitazono T. Yamada S, et al. Ther Apher Dial. 2015 Feb;19(1):73-80. doi: 10.1111/1744-9987.12221. Epub 2014 Sep 4. Ther Apher Dial. 2015. PMID: 25195562
Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.
Asamiya Y, Yajima A, Shimizu S, Otsubo S, Tsuchiya K, Nitta K. Asamiya Y, et al. Osteoporos Int. 2015 Mar;26(3):1017-28. doi: 10.1007/s00198-014-2934-8. Epub 2014 Nov 4. Osteoporos Int. 2015. PMID: 25366373
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.
Ix JH, Isakova T, Larive B, Raphael KL, Raj DS, Cheung AK, Sprague SM, Fried LF, Gassman JJ, Middleton JP, Flessner MF, Block GA, Wolf M. Ix JH, et al. J Am Soc Nephrol. 2019 Jun;30(6):1096-1108. doi: 10.1681/ASN.2018101058. Epub 2019 May 13. J Am Soc Nephrol. 2019. PMID: 31085679 Free PMC article. Clinical Trial.
Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.
Isakova T, Xie H, Barchi-Chung A, Vargas G, Sowden N, Houston J, Wahl P, Lundquist A, Epstein M, Smith K, Contreras G, Ortega L, Lenz O, Briones P, Egbert P, Ikizler TA, Jueppner H, Wolf M. Isakova T, et al. Clin J Am Soc Nephrol. 2011 Nov;6(11):2688-95. doi: 10.2215/CJN.04290511. Epub 2011 Sep 8. Clin J Am Soc Nephrol. 2011. PMID: 21903990 Free PMC article.
100 results
Jump to page
Feedback